Skip to main content

Advertisement

SpringerLink
Log in

Scleroderma (systemic sclerosis) among Nigerians

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Scleroderma and other connective tissue diseases have rarely been reported among Africans. The objective of this paper is to have a retrospective study of the clinical and investigative characteristics of scleroderma patients seen in a rheumatology clinic. This was done in a private practice rheumatology clinic in Lagos, Nigeria. Patients were identified using the American College of Rheumatology criteria for diagnosis of scleroderma. A total of 14 cases of scleroderma are reported. Most of the patients were females and diffuse scleroderma was more frequently seen. Arthritis and reflux esophagitis were the most common nondermatological presentation while Raynaud’s phenomenon and dysphagia were the least seen. Restrictive pattern of lung function tests were seen in most of those tested and pulmonary fibrosis was seen in some cases. Antinuclear antibodies were the commonest serological findings with the speckled staining pattern in most cases. Treatments were with standard medications. Scleroderma among Nigerians is rare as elsewhere and there are certain common characteristics as seen elsewhere as well as certain differences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Medsger TA Jr, Masi AT (1971) Epidemiology of systemic sclerosis. Ann Intern Med 74:714–721

    PubMed  Google Scholar 

  2. Michet CJ Jr, Mckenna CH, Elveback LR et al (1985) Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 60:105–113

    PubMed  Google Scholar 

  3. Steen VD, Oddis CV, Conte CG et al (1997) Incidence of systemic sclerosis in Alleghany County. Pennsylvania. A twenty year study of hospital diagnosed cases. 1963–1982. Arthritis Rheum 40:441–445

    Article  PubMed  CAS  Google Scholar 

  4. Laing TJ, Gillepsie BW, Toth MB et al (1997) Racial differences in scleroderma among women in Michigan. Arthritis Rheum 40:734–742

    Article  PubMed  CAS  Google Scholar 

  5. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillepsie BW, Cooper B, Laing TJ, Schottenfeld D (2003) Prevalence, incidence, survival and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48:2246–2255

    Article  PubMed  Google Scholar 

  6. Polednak AP (1987) Connective tissue responses in blacks in relation to disease: further observations. Am J Phys Anthropol 74(3):357–371

    Article  PubMed  CAS  Google Scholar 

  7. Jacyk WK (1979) Progressive systemic sclerosis; a case report from Nigeria and review of African cases. J Trop Med Hyg 82(2):42–44

    PubMed  CAS  Google Scholar 

  8. Ladipo GO (1976) Progressive systemic sclerosis (scleroderma): first case report in a Nigerian. Dermatologica 153(3):196–201

    Article  PubMed  CAS  Google Scholar 

  9. Edibam B (1972) Progressive systemic sclerosis (scleroderma; a case report). Indian Paediatr 1:47–48

    Google Scholar 

  10. Masi AT, Rodnan GP, Medsger T et al (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590

    Article  Google Scholar 

  11. Tager RE, Tikly M (1999) Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans. Rheumatology (Oxford) 38(5):397–400

    Article  CAS  Google Scholar 

  12. Maricq HR, Weinrich MC, Keil JE, Le Roy EC (1986) Prevalence of Raynaud’s phenomenon in the general population. A preliminary study by questionnaire. J Chronic Dis 34(6):423–427

    Article  Google Scholar 

  13. Gelber AC, Wigley FM, Stallings RY, Bone LR, Barker AV, Baylor I, Harris CW, Hill MN, Zeger SL, Levine DM (1999) Symptoms of Raynaud’s phenomenon in an African–American community: prevalence and self-reported cardiovascular comorbidity. J Clin Epidemol 52(5):441–446

    Article  CAS  Google Scholar 

  14. Tikly M, Burgin S, Mohanlal P, Bellingan A, George J (1996) Auto antibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations. Clin Rheumatol 15(2):143–147

    Article  PubMed  CAS  Google Scholar 

  15. Nietert PJ, Mitchell HC, Bolster MB, Shaftman SR, Tilley BC, Silver RM (2006) Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol 33(2):263–268

    PubMed  Google Scholar 

  16. Pudifin DJ, Dinnematin H, Duursma J (1991) Anti nuclear antibodies in systemic sclerosis: clinical and ethnic associations. S Afr Med J 80(9):438–440

    PubMed  CAS  Google Scholar 

  17. Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger TA Jr (1994) Racial differences in the distribution of systemic sclerosis related serum antinuclear antibodies. Arthritis Rheum 37(6):902–906

    Article  PubMed  CAS  Google Scholar 

  18. Le Roy EC (1996) Systemic sclerosis: a vascular perspective. Rheum Dis Clin North Am 22(4):675–694

    Article  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Rheumatology Unit, Department of Medicine, Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria

    O. O. Adelowo & S. Oguntona

  2. P. O. Box 7231, Ikeja, Lagos, Nigeria

    O. O. Adelowo

Authors
  1. O. O. Adelowo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Oguntona
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. O. Adelowo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adelowo, O.O., Oguntona, S. Scleroderma (systemic sclerosis) among Nigerians. Clin Rheumatol 28, 1121–1125 (2009). https://doi.org/10.1007/s10067-009-1191-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-009-1191-2

Keywords

Search

Navigation